??????
|
|
?????? ??
- ???
- 139°C
- ?? ?
- 646.2±55.0 °C(Predicted)
- ??
- 1.263±0.06 g/cm3(Predicted)
- ?? ??
- 2-8°C
- ???
- DMSO: ???5mg/mL, ??(??)
- ?? ?? (pKa)
- 14.42±0.20(Predicted)
- ??? ??
- ??
- ??
- ???? ????
- Merck
- 14,785
- BCS Class
- 2
- ???
- ??? ?? ?????? 2? ?? ??????. DMSO ?? ??? ??? -20°?? ?? 3?? ?? ??? ? ????.
- InChI
- InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)
- InChIKey
- CEUORZQYGODEFX-UHFFFAOYSA-N
- SMILES
- N1C2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)CCC1=O
- CAS ??????
- 129722-12-9(CAS DataBase Reference)
??
- ?? ? ?? ??
- ?? ? ???? ?? (GHS)
| ??? ?? | F,Xn | ||
|---|---|---|---|
| ?? ???? ?? | 11-20/21/22-36 | ||
| ????? | 16-36/37 | ||
| ????(UN No.) | UN 1993C 3 / PGIII | ||
| WGK ?? | 3 | ||
| RTECS ?? | VC8275950 | ||
| HS ?? | 29349990 | ||
| ?? ?? ??? | 129722-12-9(Hazardous Substances Data) | ||
| ?? | TDLo ivn-dog: 0.03 mg/kg/10M TXAPA9 173,120,2001 |
?????? C??? ??, ??, ??
??? ??
Colourless Flake Crystalline Solid??
A deuterated version of Aripiprazole, a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity. Please note that users have reported separation of this compound and aripiprazole under normal-phase and reverse-phase?? ??
Aripiprazole (Abilify). The newest, longactingaripiprazole (an arylpiperazine quinolinone derivative),appears to be partial agonist of D2 receptors (i.e., itstimulates certain D2 receptors while blocking others dependingon their locations in the brain and the concentrationof drug). Bioavailability of aripiprazole is around 87%, with peak plasma concentration attained at 3 to 5 hours afterdosing. It is metabolized by dehydrogenation, oxidative hydroxylation, and N-dealkylation, largelymediated by hepatic CYPs 3A4 and 2D6.The diphenylbutylpiperidine class can be considered amodification of the fluorobutyrophenone class. Because oftheir high lipophilicity, the compounds are inherently longacting. Pimozide has been approved for antipsychotic use,and penfluridol has undergone clinical trials in the UnitedStates. Overall, side effects for the two compounds resemblethose produced by the fluorobutyrophenones.
???
A poison.Safety Profile
A poison by intravenous route.When heated to decomposition it emits toxic vapors ofNOx and Cl-.?????? ?? ?? ? ???
???
M-??????
1,4-??????
??????
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone
Aripiprazole hydrochloride
2(1H)-Quinolinone, 3,4-dihydro-7-(2-propen-1-yloxy)-
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone
3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone
1-(2,3-??????)-???????
?? ??
?????? ?? ??
???( 690)?? ??
| ??? | ?? | ??? | ?? | ?? ? | ?? |
|---|---|---|---|---|---|
| Protheragen-ING | +16313385890 |
info@protheragen-ing.com | United States | 3868 | 58 |
| Changzhou Rokechem Technology Co., Ltd. | 18758118018 |
sales001@rokechem.com | China | 255 | 58 |
| Hebei Mujin Biotechnology Co.,Ltd | +86 13288715578 +8613288715578 |
sales@hbmojin.com | China | 12822 | 58 |
| Xiamen Wonderful Bio Technology Co., Ltd. | +8613043004613 |
Sara@xmwonderfulbio.com | China | 283 | 58 |
| Guangzhou Tengyue Chemical Co., Ltd. | +86-86-18148706580 +8618826483838 |
evan@tyvovo.com | China | 147 | 58 |
| Nantong Guangyuan Chemicl Co,Ltd | +undefined17712220823 |
admin@guyunchem.com | China | 615 | 58 |
| Hangzhou Hyper Chemicals Limited | +86-0086-57187702781 +8613675893055 |
info@hyper-chem.com | China | 295 | 58 |
| BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 +86-18600796368 |
sales@sjar-tech.com | China | 484 | 58 |
| Capot Chemical Co.,Ltd. | +86-（0）57185586718 +86-13336195806 |
sales@capot.com | China | 29730 | 60 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21631 | 55 |
?????? ?? ??:
(??-???????)????
OPC-14714
Aripiprazole N1-Oxide
Aripiprazole Dimer
Aripiprazole Related CoMpound B
Aripiprazole N4-Oxide
1-(2,6-dichlorophenyl)piperazine
Aripiprazole Metabolite
Aripiprazole iMpurity 2
2-Deschloro Aripiprazole
Aripiprazole Impurity 19
7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE
1,4-BIS[3,4-DIHYDRO-2(1H)-QUINOLINON-7-OXY]BUTANE
Aripiprazole iMpurity 3
3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone
N-(2,3-Dichloro-phenyl)-N'-[2-(2,3-dichloro-phenylamino)-ethyl]-ethane-1,2-diamine
N-(2-Chloro-ethyl)-N'-(2,3-dichloro-phenyl)-ethane-1,2-diamine
Aripiprazole N,N-Dioxide